Table 1.
Patients’ and treatment characteristics
| Variable | N (range,%) |
|---|---|
| Median Age (range) | 68(46/85) |
| Sex | |
| male | 71 (65.7) |
| female | 37 (34.3) |
| PS ECOG | |
| 0 | 62 (57.4) |
| 1 | 39 (36.1) |
| 2 | 5 (4.6) |
| Smoking History | |
| unknown | 2 (1.8) |
| Never | 3 (2.7) |
| Former | 48 (44.4) |
| Current | 55 (50.9) |
| Tumor Location | |
| RUL | 42 (38.8) |
| ML | 3 (2.7) |
| RIL | 13 (12) |
| LUL | 35 (32.4) |
| LIL | 15 (13.8) |
| AJCC Stage | |
| IIIA | 45 (41.6) |
| IIIB | 60 (55.5) |
| IIIC | 3 (2.7) |
| Histology | |
| Adenocarcinoma | 57 (52.7) |
| Squamous cell carcinoma | 37 (34.2) |
| Other NSCLC | 14 (12.9) |
| PD-L1 status | |
| < 1% | 17 (15.7) |
| >=1%<50% | 33 (30.5) |
| >=50% | 16 (14.8) |
| unknown | 42 (38.8) |
| Chemotherapy Modality | |
| no chemotherapy | 3 (2.7) |
| Concomitant | 42 (38.8) |
| Sequential | 63 (58.3) |
| Chemotherapy Regimen | |
| Carboplatin + Paclitaxel | 37 (34.3) |
| Other | 68 (62.9) |
Abbreviations: RUL: right upper lobe, ML: medium lobe, RIL: right inferior lobe, LUL: left upper lobe, LIL: left inferior lobe